DSpace Repository

Modulation of mitochondrial Ca2+ uptake by estrogen receptor agonists and antagonists

Show simple item record

dc.creator Lobatón, Carmen D.
dc.creator Vay, Laura
dc.creator Hernández-SanMiguel, Esther
dc.creator Santo-Domingo, Jaime
dc.creator Moreno, Alfredo
dc.creator Montero, Mayte
dc.creator Álvarez, Javier
dc.date 2008-06-20T09:07:37Z
dc.date 2008-06-20T09:07:37Z
dc.date 2005-08
dc.date.accessioned 2017-01-31T01:44:43Z
dc.date.available 2017-01-31T01:44:43Z
dc.identifier British Journal of Pharmacology 145(7): 862–871 (2005)
dc.identifier 0007-1188
dc.identifier http://hdl.handle.net/10261/5203
dc.identifier 10.1038/sj.bjp.0706265
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10261/5203
dc.description Ca2+ uptake by mitochondria is a key element in the control of cellular Ca2+ homeostasis and Ca2+-dependent phenomena. It has been known for many years that this Ca2+ uptake is mediated by the mitochondrial Ca2+ uniporter, a specific Ca2+ channel of the inner mitochondrial membrane. We have shown previously that this channel is strongly activated by a series of natural phytoestrogenic flavonoids. We show here that several agonists and antagonists of estrogen receptors (ERs) also modulate the activity of the uniporter. The specific α-ER agonist 4,4′,4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT) was the strongest activator, increasing the rate of mitochondrial Ca2+ uptake in permeabilized HeLa cells by 10-fold at 2 μM. Consistently, PPT largely increased the histamine-induced mitochondrial [Ca2+] peak and reduced the cytosolic one. Diethylstilbestrol and 17-β-estradiol (but not 17-α-estradiol) were active at pharmacological concentrations while the β-estrogen-receptor agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN) was little effective. The ER modulators tamoxifen and 4-hydroxy-tamoxifen inhibited mitochondrial Ca2+ uptake (IC50 2.5±1.5 and 2.5±1.4 μM, mean±s.d., respectively) both in the presence and in the absence of PPT, but raloxifene and the pure estrogen antagonist ICI 182,780 produced no effect. Activation by PPT was immediate and inhibition by tamoxifen or 4-hydroxy-tamoxifen required only 5 min to reach maximum. Tamoxifen did not modify mitochondrial membrane potential and PPT induced a slow mitochondrial depolarization at higher concentrations than those required to activate mitochondrial Ca2+ uptake. These results suggest that some kind of ER or related protein located in mitochondria controls the activity of the Ca2+ uniporter by a nongenomic mechanism. This novel mechanism of action of estrogen agonists and antagonists can provide a new interpretation for several previously reported effects of these compounds.
dc.description Financial support from Dirección General de Enseñanza Superior, Ministerio de Ciencia y Tecnología (BFI2002-01397), from Junta de Castilla y León (VA 005/02) and from Fondo de Investigaciones Sanitarias (PI040789) are gratefully acknowledged. J.S. and E.H.-S. hold FPI and FPU fellowships, respectively, from the Spanish Ministerio de Educación y Ciencia. L.V. holds a fellowship from Fondo de Investigaciones Sanitarias (Spanish Ministerio de Sanidad).
dc.description Peer reviewed
dc.format 22195 bytes
dc.format application/pdf
dc.language eng
dc.publisher Nature Publishing Group
dc.rights closedAccess
dc.subject Aequorin
dc.subject Ca2+-uniporter
dc.subject Diethylstilbestrol
dc.subject DPN
dc.subject Estradiol
dc.subject Estrogen
dc.subject Mitochondria
dc.subject PPT
dc.subject SB202190
dc.subject Tamoxifen
dc.title Modulation of mitochondrial Ca2+ uptake by estrogen receptor agonists and antagonists
dc.type Artículo


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account